CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes

Thumbnail Image

Tarih

2023

Yazarlar

Schnell, Oliver
Barnard\\-Kelly, Katharine
Battelino, Tadej
Ceriello, Antonio
Larsson, Helena Elding
Fernandez\\-Fernandez, Beatriz
Forst, Thomas
Frias, Juan \\-Pablo
Gavin III, James R.
Giorgino, Francesco

Süreli Yayın başlığı

Süreli Yayın ISSN

Cilt Başlığı

ISSN

Cilt

Sayı

Yayınevi

VERLAG KIRCHHEIM

Özet

Açıklama

Anahtar kelimeler

Cardiovascular disease Chronic kidney disease CGM Diabetes Finerenone, GLP\\-1 RA Guidelines Heart failure MASLD NAFLD Obesity SGLT2 inhibitor, Teplizumab

Alıntı

URI

https://openaccess.acibadem.edu.tr/handle/11443/6414

Koleksiyonlar

WOS

Endorsement

Review

Supplemented By

Referenced By